Inicio › Leucemia linfocítica crónica › Distrito de Columbia › Washington
Ensayos clínicos de Leucemia linfocítica crónica en Washington, DC
22 estudios para Leucemia linfocítica crónica buscan participantes en centros de Washington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
ReclutandoFase 1/2
- American Oncology Partners of Maryland Pa, Bethesda · A 7 mi de distancia
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
ReclutandoFase 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · A 7 mi de distancia
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · A 7 mi de distancia
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
ReclutandoFase 3
- GC2202 Study Site 111, Bethesda · A 7 mi de distancia
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
ReclutandoFase 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · A 7 mi de distancia
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
ReclutandoFase 3
- American Oncology Partners of Maryland Pa, Bethesda · A 7 mi de distancia
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ReclutandoFase 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ReclutandoFase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · A 7 mi de distancia
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ReclutandoFase 2
- Maryland Oncology Hematology, Silver Spring · A 7 mi de distancia
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
ReclutandoFase 1 temprana
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ReclutandoFase 3
- American Oncology Partners of Maryland, PA, Bethesda · A 7 mi de distancia
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
ReclutandoFase 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · A 7 mi de distancia
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
ReclutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- National Institute of Health, Bethesda · A 7 mi de distancia
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ReclutandoFase 2
- American Oncology Partners, PA, Bethesda · A 7 mi de distancia
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ReclutandoFase 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · A 7 mi de distancia
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · A 7 mi de distancia
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Ensayos de Leucemia linfocítica crónica en otras ciudades
- Boston, MA31 estudios
- Columbus, OH28 estudios
- Durham, NC27 estudios
- Seattle, WA20 estudios
- Rochester, MN18 estudios
- New York City, NY18 estudios
- Houston, TX17 estudios
- Baldwin Park, CA16 estudios
- Milwaukee, WI15 estudios
- Chicago, IL14 estudios
- Cincinnati, OH14 estudios
- Nashville, TN13 estudios
Otros estudios en Washington
- Cáncer (todos los tipos)58 estudios
- Cáncer de pulmón de células no pequeñas55 estudios
- Cáncer de seno46 estudios
- Cáncer metastásico43 estudios
- Cáncer de pulmón41 estudios
- Cáncer de próstata38 estudios
- Obesidad33 estudios
- Cáncer del colon y del recto29 estudios
- Enfermedad cardiovascular28 estudios
- Cáncer de vejiga26 estudios
- Leucemia mielógena aguda24 estudios
- Cáncer de ovario23 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.